What happens when you can’t attend the conference you’ve been dreaming about?

For Eric Dreshfield, the answer was simple: create his own.

In this inspiring episode of the Life Sciences Sales Lab, host Shannon J. Gregg sits down with Salesforce legend Eric Dreshfield to explore how authentic relationships, curiosity, and community-building transformed his career.

Eric shares his remarkable journey from attending local Salesforce user groups to founding Midwest Dreamin'—a grassroots conference that sparked a worldwide movement of Dreamin’ events. Along the way, he reveals how networking led directly to career opportunities in life sciences and why helping others has become the cornerstone of his personal brand.

This episode is packed with practical insights for anyone looking to grow their career, expand their network, and turn one idea into a lasting impact.

In this episode of Life Sciences Sales Lab, Dr. Shannon Gregg is joined by Natalie Bulger to perform a forensic analysis of the VA’s $16 billion EHR transformation. For a sales executive, a signed contract is only the beginning; the real battle is surviving the "Last Mile" of implementation where fragmented leadership and "shadow workflows" can derail even the most strategic enterprise win.

Natalie shares "war stories" from the front lines of the VA rollout, offering a masterclass in identifying the hidden organizational landmines that turn a flagship deal into a "Hamster Wheel" of endless technical debt. If you are selling eClinical or healthcare technology to complex, multi-layered organizations, this conversation is your blueprint for protecting your footprint and ensuring long-term account viability.

Key Takeaways for Sales Leaders:

The "Shadow" Org Chart: Why selling to the C-suite isn't enough if you haven't mapped the disconnected IT silos that actually control the "Go-Live".

M&A and Leadership Volatility: How to "insulate" your deal against the leadership turnover that frequently follows a major acquisition or contract award.

The "Anti-Agile" Reality: Why rushing a Minimum Viable Product (MVP) into a clinical setting is a recipe for "Defiant Adoption" and lost renewals.

Closing the Value Gap: Moving the conversation from "Software Features" to "Risk Mitigation" to ensure your tool remains a "must-survive" asset during budget cuts.

In this episode of the Life Sciences Sales Lab podcast, Shannon explores one of the biggest conversations shaping commercial organizations today: AI in life sciences sales.

With constant pressure to move faster, improve execution, and stay competitive, artificial intelligence is becoming impossible to ignore. But amid all the excitement, what’s actually delivering value—and what’s simply industry hype?

This episode breaks down: • Where AI is genuinely improving commercial performance • Why productivity and prioritization matter more than flashy tools • The biggest misconceptions leaders should avoid • How adoption, trust, and execution still determine success • Why human relationships remain the foundation of life sciences sales

If you're a commercial leader trying to separate meaningful innovation from noise, this conversation offers a practical perspective on how organizations can use AI thoughtfully in 2026 and beyond.

In this recap episode of the Life Sciences Sales Lab Podcast, Dr. Shannon Gregg sits down with Rick Ward, Chief Commercial Officer, to explore what it really takes to drive growth and innovation in the fast-evolving life sciences industry. From selling complex, non-commoditized solutions to becoming a trusted advisor in pharma, Rick shares powerful insights on modern sales strategy, change management, and why education is the key to success in today’s market.

They also discuss how industry shifts like COVID, decentralized clinical trials, and emerging GLP-1 research are reshaping the commercial landscape—and what sales professionals must do to stay ahead.

If you're in life sciences, healthcare, biotech, or B2B sales, this episode delivers practical takeaways on building demand, navigating complexity, and creating real impact.

In this episode of Life Sciences Sales Lab, Dr. Shannon J. Gregg explores the ROI of trust and why it has become one of the most valuable assets in enterprise sales.

As pricing pressure increases and products become harder to differentiate, trust plays a critical role in influencing buying decisions, strengthening partnerships, and accelerating long-term growth.Tune in to learn how sales leaders can shift conversations from product features to measurable outcomes, build stronger client confidence, and win in a competitive market.

Sales teams are under constant pressure—targets, timelines, and now, continuous change.In this recap episode, we break down key insights from a conversation with Angela, focusing on why sales teams resist change, how sales operations is often misunderstood, and what actually drives real adoption.

From shifting perception to building simple, repeatable habits—this episode highlights what it truly takes to make systems like Salesforce work with your team, not against them.If you're leading sales, working in ops, or driving digital transformation—this one’s for you.

In this episode of The 2026 Strategy Lab, we dive deep into the evolving landscape of CRM, data confidence, and site-centric strategies with Andrew Duncan.As the industry shifts toward smarter, more integrated systems, the question is no longer how much data you have—but how confidently you can use it. Andrew breaks down what “data confidence” really means in 2026, why site-centricity is becoming a game-changer, and how organizations can rethink their CRM strategies to stay ahead.

From practical insights to future-forward thinking, this conversation explores:

• The shift from data collection to data clarity
• Why site-centric models are redefining execution
• The future role of CRM in a hyper-connected ecosystem
• What leaders must prioritize now to stay competitive

If you're navigating digital transformation or rethinking your CRM strategy, this episode is your playbook for what’s next.

In this recap episode of the Life Sciences Sales Lab, we break down the most powerful insights from Joe Dustin on what actually drives sales success in pharma.

From why clients resist change, to when pre-sales becomes critical, to how to build a high-performing solution consulting team — this episode is a masterclass in modern B2B sales.

If you're building, scaling, or optimizing a sales team in a complex industry, this is your playbook.

Key takeaways:

• The real reason pharma clients don’t change
• When to introduce pre-sales for scale
• How to structure and measure a high-performing sales team

Listen full episode on Apple Podcast & Spotify:

Scaling Success: The Blueprint for a High-Impact Life Sciences Pre-Sales Team

In this episode, we explore how the sales landscape is shifting and why understanding the buyer’s perspective has never been more important.

Joining us is the author of The Buyer’s Way, who shares insights on how successful sales teams adapt to modern buying behavior.

We discuss:

• Why traditional selling approaches are becoming less effective
• How today’s buyers make decisions differently
• What sales teams can do to build trust and deliver real value

This conversation offers practical insights for anyone involved in B2B sales, commercial strategy, and life sciences selling.

If you're looking to improve how you connect with buyers and close meaningful opportunities, this episode is for you.

In this highlight episode of the Life Sciences Sales Lab, Shannon Gregg revisits three powerful questions from her conversation with Scott Ballenger.Together, they explore what it takes to succeed in the complex world of life sciences sales — from navigating multiple stakeholders to understanding how the industry is evolving, and the lessons Scott would share with his younger self.

In this episode, you’ll hear Scott’s perspective on:

• Selling to multiple stakeholders in complex life sciences deals
• The current state of life sciences sales and go-to-market strategies
• The advice he would give his younger self starting out in the industry

Three questions. Three valuable insights into the science of selling to science.